Does high hepatic bioavailability enhance the effect of oral compared to subcutaneous glucocorticoids? van Geel EH, Boers M, Hartman L, Smulders YM, et al. Clin Exp Rheumatol 2024;42:2265-2267.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

van Geel EH, Boers M, Hartman L, Smulders YM, et al. Does high hepatic bioavailability enhance the effect of oral compared to subcutaneous glucocorticoids? Clin Exp Rheumatol 2024;42:2265-2267.
PMID: 38976293